Publicaciones en colaboración con investigadores/as de Hospital Infanta Leonor (12)

2022

  1. Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 8, pp. 2292-2312

2021

  1. Deep sequencing of prostaglandin-endoperoxide synthase (PTGE) genes reveals genetic susceptibility for cross-reactive hypersensitivity to NSAID

    British Journal of Pharmacology, Vol. 178, Núm. 5, pp. 1218-1233

  2. Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs

    Frontiers in Pharmacology, Vol. 12

2016

  1. Role of Histamine Release Test for the Evaluation of Patients with Immediate Hypersensitivity Reactions to Clavulanic Acid

    International Archives of Allergy and Immunology, Vol. 168, Núm. 4, pp. 233-240

2015

  1. Genetic variants in arachidonic acid pathway genes associated with NSAID-exacerbated respiratory disease

    Pharmacogenomics, Vol. 16, Núm. 8, pp. 825-839

  2. HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping

    Journal of Allergy and Clinical Immunology, Vol. 135, Núm. 1, pp. 253-259.e10

2014

  1. Variants of CEP68 gene are associated with acute urticaria/angioedema induced by multiple non-steroidal anti-inflammatory drugs

    PLoS ONE, Vol. 9, Núm. 3

2013

  1. Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations

    Pharmacogenomics, Vol. 14, Núm. 15, pp. 1857-1869

2012

  1. Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria

    Clinical and Experimental Allergy, Vol. 42, Núm. 12, pp. 1772-1781

  2. The Diamine Oxidase Gene Is Associated with Hypersensitivity Response to Non-Steroidal Anti-Inflammatory Drugs

    PLoS ONE, Vol. 7, Núm. 11

2011

  1. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: Patterns of response

    Clinical and Experimental Allergy, Vol. 41, Núm. 1, pp. 86-95

  2. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 66, Núm. 11, pp. 1428-1433